Suchergebnisse - "Knapper, Steven"

PubPharm (9)

1

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Russell, N. | Wilhelm-Benartzi, C. | Othman, J. | +117

2

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Harrison, C. | Nangalia, J. | Boucher, R. | +30

3

A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia : Results from the LI-1 trial

enthalten in: British journal of haematology | 2023

von Mussai, F. | De Santo, C. | Cheng, P. | +13

4

Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patients

enthalten in: Blood advances | 2021

von Dennis, M. | Thomas, I. | Ariti, C. | +11

5

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy : results from a multicenter, randomized, phase 2/3 study

enthalten in: Leukemia | 2021

von Montesinos, P. | Roboz, G. | Bulabois, C. | +22

6

Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide

enthalten in: Blood | 2017

von Harrison, C. | Mead, A. | Panchal, A. | +18

CommentIn: Blood. 2017 Oct 26;130(17):1873-1874. - PMID 29074591

7

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML

enthalten in: Blood | 2017

von Knapper, S. | Russell, N. | Gilkes, A. | +10

CommentIn: Blood. 2017 Mar 2;129(9):1061-1062. - PMID 28254820

8

Elacytarabine in relapsed/refractory acute myeloid leukaemia : an evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile

enthalten in: Leukemia research | 2014

von Knapper, S. | Chevassut, T. | Duarte, R. | +8

9

Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival

enthalten in: Blood | 2013

von Burnett, A. | Russell, N. | Hunter, A. | +9

1
[1]